Stopped: Temporary hold.
The purpose of this pilot interventional study is to collect preliminary data on administering packed red blood cell (PRBC) during cardiac arrest (CA). The primary objective is to assess the feasibility of PRBC transfusion during cardiac CA to help optimize the methods required to augment cerebral and other vital organ oxygen delivery during cardiopulmonary resuscitation (CPR). The secondary objectives are to assess the effect of PRBC transfusion during prolonged cardiac arrests on cerebral oxygenation, end tidal carbon dioxide (ETCO2), return of spontaneous circulation (ROSC), survival to discharge, biomarkers of neural injury and inflammation, and neurological outcomes at hospital discharge, 30 days post-CA, and 90 days post-CA.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Time (in mins) to administration of Packed Red Blood Cells (PRBC)
Timeframe: During Cardiopulmonary Resuscitation (CPR) (up to 20 minutes)
Frequency of antibody-mediated transfusion reactions
Timeframe: 6-72 hours after Return of Spontaneous Circulation (ROSC)
Frequency of non-immune reactions
Timeframe: 6-72 hours after ROSC
Change in frequency of right ventricular (RV) dilatation
Timeframe: Baseline, up to 20 minutes post administration of PRBC
All-cause mortality
Timeframe: Up to 30 days after the last day of study participation
Proportion of patients with unfavorable neurological outcomes
Timeframe: Up to 30 days post-Cardiac Arrest (CA)